Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Washington Legal Foundation: New Developments and Notable Trends for Drugs and Medical Devices

Summary

Speakers

William M. Jay

Related Content

Supreme Court Grants Review in ERISA Class Action Challenging Plan Sponsor’s Recordkeeping Arrangement

Texas Court Finds FTC Noncompete Ban Unlawful with Nationwide Effect

The Chevron Doctrine Is Dead. What Are the Implications for Business?

U.S. Supreme Court Significantly Curtails SEC Enforcement Forum Discretion

Supreme Court Adopts New Standard for Establishing Adverse Employment Action Element in Title VII Cases

Supreme Court Rejects Securities Lawsuit Based On “Pure Omission” From SEC Filings

2023 Year in Review: Major U.S. Supreme Court and Appellate Cases

ERISA Litigation Update

Goodwin Earns Top Firm and Attorney Rankings in Patexia’s 2024 CAFC Intelligence Report

Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.

Best Lawyers Best Law Firms 2025 Names Goodwin Biotechnology and Life Sciences Law Firm of the Year for the Eighth Time and Recognizes 55 Practice Areas

Benchmark Litigation US 2025 Recognizes 45 Goodwin Litigators

Bruised Supreme Court Returns to Bench With Possible Election Cases Looming (The New York Times)

Goodwin Named Venture Capital Firm of the Year, Hatch-Waxman Litigation Firm of the Year and Life Cycle Firm of the Year at the 2024 LMG Life Sciences Americas Awards

Benchmark Litigation Names Fourteen Goodwin Partners to 40 & Under Hot List 2024

Circuits Reckon With Appeals ‘Caught in the Middle’ Post-Chevron (Bloomberg Law)

Life Sciences

Appellate and Supreme Court Litigation

Products Litigation & Counseling